6505--Intent to Sole Source: RADIUM-223 Dichloride (Xofigo) IDIQ

Closed Pre-Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
36C26120Q0630
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Department of Veterans Affairs VA Sierra Pacific Network (Visn 21) Mather 95655

Notice details come from SAM.gov. Updated .

Notice text

Department of Veterans Affairs (VA) Network Contracting Office 21 (NCO 21) hereby gives notice of the Government s intent to establish a single award fixed price indefinite delivery/ indefinite quantity (IDIQ) contract for a period of performance of 5 years with Cardinal Health 414, LLC: 7000 Cardinal Pl. Dublin, OH 43017 to acquire Xofigo (radium Ra-223 dichloride) injections, a pharmaceutical used to treat advanced prostate cancer. This IDIQ will be used as a simplified method of filling anticipated repetitive needs for providing Xofigo to treat patients receiving nuclear medicine services at the VA Northern California Health Care System, Mather: 10535 Hospital Way, Mather, CA 95655.

This IDIQ will be established with a single source, Cardinal Health 414, LLC because they are the sole distributor of Xofigo. Determination of this single source procurement is in accordance with Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements per 41 USC §3304(a)(1) as implemented by FAR 6.302-1. It is the Government s belief that the proposed candidate is the only provider Radium 223 Dichloride (Xofigo) that can meet the agency s needs. The applicable North American Industry Classification System (NAICS) code is 325412 and the Federal Supply Code (FSC) is 6505.

This notice of intent is not a request for competitive quotes. Telephone requests will not be accepted. However, any business that believes it can provide the Radium 223 Dichloride (Xofigo) may give written notice to moneque.rodriguez@va.gov by 3:00PM Hawaii Time on July 15, 2020. All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirement. Responses will be considered by the Government; however, a determination by the Government not to compete the proposed acquisition based upon responses of this notice is solely within the discretion of the Government.

THIS SYNOPSIS DOES NOT COMMIT THE GOVERNMENT TO CONTRACT FOR ANY SUPPLY OR SERVICE. THE GOVERNMENT WILL NOT PAY FOR ANY INFORMATION OR ADMINISTRATIVE COSTS INCURRED IN RESPONSE TO THIS SYNOPSIS.

Files

File Type Posted
36C26120Q0630_1.docx DOCX document
J_A-Xofigo-Redacted_Redacted.pdf PDF
36C26120Q0630.pdf PDF

Notice history

Notice Type Posted
6505--RADIUM-223 Dichloride (Xofigo) IDIQ Award Award Notice
This notice Latest pre-solicitation Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors